371 related articles for article (PubMed ID: 11219487)
1. Bodyweight gain with atypical antipsychotics. A comparative review.
Wetterling T
Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
3. [Weight gain from atypical neuroleptics--an underreported adverse effect?].
Wetterling T
Fortschr Neurol Psychiatr; 2000 Dec; 68(12):546-56. PubMed ID: 11200858
[TBL] [Abstract][Full Text] [Related]
4. [Atypical antipsychotic drugs].
Kahn RS
Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Kapur S; Remington G
Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
[TBL] [Abstract][Full Text] [Related]
6. Review of atypical antipsychotics and weight gain.
Sussman N
J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886
[TBL] [Abstract][Full Text] [Related]
7. The effects of novel antipsychotics on glucose and lipid levels.
Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
[TBL] [Abstract][Full Text] [Related]
8. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
9. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
10. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.
Potvin S; Stip E; Roy JY
Int Clin Psychopharmacol; 2003 May; 18(3):121-32. PubMed ID: 12702890
[TBL] [Abstract][Full Text] [Related]
11. Use of atypical antipsychotics in mood disorders.
Weizman R; Weizman A
Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine: an updated review of its use in the management of schizophrenia.
Bhana N; Foster RH; Olney R; Plosker GL
Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
[TBL] [Abstract][Full Text] [Related]
14. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
[TBL] [Abstract][Full Text] [Related]
15. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
Kapur S; Seeman P
Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of weight gain with antipsychotics.
Casey DE; Zorn SH
J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
[TBL] [Abstract][Full Text] [Related]
17. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
Deveney AM; Waddington JL
Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
Tarazi FI; Zhang K; Baldessarini RJ
J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics and weight gain--a systematic review.
Taylor DM; McAskill R
Acta Psychiatr Scand; 2000 Jun; 101(6):416-32. PubMed ID: 10868465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]